Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Tranexamic acid (TXA) reduces head injury deaths. The CRASH-4 trial aims to assess the effects of early intramuscular TXA on intracranial haemorrhage, disability, death, and dementia in older adults with symptomatic mild head injury
Epistemonikos ID: b0b0b17ae4446164870e2f11adc71384e6da0ebb
First added on: May 07, 2024